EX-99 2 ex_810920.htm EXHIBIT 99 ex_810920.htm
 

Exhibit 99

 

NEWS RELEASE

logo.jpg

 

STANDEX INTERNATIONAL CORPORATION █ SALEM, NH 03079 █ TEL (603) 893-9701 █ WEB www.standex.com

 

STANDEX REPORTS FISCAL THIRD QUARTER 2025 FINANCIAL RESULTS

 

 

Sales Increased 17.2% with Contributions from Acquisitions Partially Offset by Organic Decline; Fast Growth End Markets Increased to 29% of Total Sales

 

GAAP Gross Margin of 39.7%; Record Adjusted Gross Margin of 42.3% - Up 140 bps Sequentially and 230 bps YOY

 

GAAP Operating Margin of 12.6%; Record Adjusted Operating Margin of 19.4% - Up 70 bps Sequentially and 280 bps YOY

 

Electronics Book to Bill of 0.98 Indicating Market Stability; Electronics Organic Bookings up >10% YOY; Strong Amran/Narayan Group Sales of >$33 Million with Book to Bill of 1.04

 

Acquired McStarlite, a Leading Provider of Complex Sheet Metal Aerospace Components, Serving Space, Defense, and Commercial Aviation End Markets

 

SALEM, NH May 1, 2025Standex International Corporation (NYSE: SXI) today reported financial results for the third quarter of fiscal year 2025 ended March 31, 2025.

 

Summary Financial Results - Total

                                       

($M except EPS and Dividends)

 

3Q25

   

3Q24

   

2Q25

   

Y/Y

   

Q/Q

 

Net Sales

  $ 207.8     $ 177.3     $ 189.8       17.2 %     9.5 %

Operating Income – GAAP

  $ 26.3     $ 21.8     $ 8.5       20.2 %     210.2 %

Operating Income – Adjusted

  $ 40.3     $ 29.4     $ 35.5       37.3 %     13.8 %

Operating Margin % - GAAP

    12.6 %     12.3 %     4.5 %  

+ 30 bps

   

+ 820 bps

 

Operating Margin % - Adjusted

    19.4 %     16.6 %     18.7 %  

+ 280 bps

   

+ 70 bps

 

Net Income from Continuing Ops – GAAP

  $ 21.9     $ 15.9     $ 0.9       37.6 %     2420.0 %

Net Income from Continuing Ops – Adjusted

  $ 23.5     $ 22.3     $ 23.0       5.6 %     2.5 %
                                         

EBITDA

  $ 35.7     $ 28.4     $ 16.1       25.7 %     122.0 %

EBITDA margin

    17.2 %     16.0 %     8.5 %  

+120 bps

   

+ 870 bps

 

Adjusted EBITDA

  $ 45.3     $ 34.5     $ 39.6       31.3 %     14.4 %

Adjusted EBITDA margin

    21.8 %     19.5 %     20.9 %  

+ 190 bps

   

+ 90 bps

 
                                         

Diluted EPS – GAAP

  $ 1.81     $ 1.35     $ 0.07       35.4 %     2407.0 %

Diluted EPS – Adjusted

  $ 1.95     $ 1.88     $ 1.91       3.7 %     2.2 %

Dividends per Share

  $ 0.32     $ 0.30     $ 0.32       6.7 %     0.0 %
                                         

Free Cash Flow

  $ 3.5     $ 19.3     $ 2.2       -81.9 %     59.1 %
                                         

Funded Debt to EBITDA per the Credit Facility

 

2.8x

   

0.6x

   

2.7x

      366.7 %     3.7 %

Net Debt to EBITDA

 

3.0x

   

0.1x

   

2.9x

      NM       3.4 %

 

Third Quarter Fiscal 2025 Results

 

Commenting on the quarter’s results, President and Chief Executive Officer David Dunbar said, “Following strong operating performance in the fiscal second quarter, we achieved several new records in our fiscal third quarter: record sales since the divestment of the Refrigeration business in April 2020, record adjusted gross margin of 42.3%, and record adjusted operating margin of 19.4%. These results reflect the continued solid operational performance from core businesses, a full quarter of ownership of the fast-growing Amran/Narayan group, and contribution from the recent McStarlite acquisition. Our fast growth market sales totaled $60.4 million or approximately 29% of total sales and are well on track to our expectations for the fiscal year of approximately $170 million. We remain confident about the Company’s exposure to positive secular trends in electrical grid, electric and hybrid vehicles, renewable energy, commercialization of space, and defense, and we are reaffirming our long-term target for fast growth market sales of $340 million plus by fiscal year 2028. In addition, we launched three additional new products in the fiscal third quarter totaling 13 year-to-date, achieving our previously committed target of over a dozen and delivering more than 2% of incremental sales.”

 

1

 

“While we cannot predict the impact of new tariffs on global trade and economic growth, our regional presence, strong customer relationships, and our disciplined approach to pricing and productivity actions position us well to manage through these challenges. Most of our supply chain is strategically located to service regional demand. China imports to the US approximately 6% of our cost of goods sold. We plan to continue to invest in our key strategic growth priorities, while closely managing our cost structure, driving productivity and pricing actions and seeking alternate sources of supply to further reduce our imports from China. We remain on track to achieve our long-term financial targets by fiscal 2028 and remain confident in our ability to pay down debt and reduce our net leverage ratio.”

 

“In early February, we acquired California-based McStarlite. The integration is on track, and we are excited about our expanded product breadth and forming capabilities in commercial aviation, space and defense applications. We expect the acquisition to be accretive to earnings in the first year of ownership.”

 

Outlook

 

In fiscal fourth quarter 2025, on a sequential basis, the Company expects slightly to moderately higher revenue, driven by the impact of recent acquisitions, higher sales into fast growth end markets, and realization of pricing initiatives. On a sequential basis, the Company expects slightly to moderately higher adjusted operating margin, benefiting from higher revenue and realization of productivity actions, partially offset by higher tariff costs and targeted investments in selling, marketing, and R&D.

 

Third Quarter Segment Operating Performance

 

Electronics (54% of sales; 68% of segment adjusted operating income)

 

   

3Q25

   

3Q24

   

% Change

 

Electronics ($M)

                       

Revenue

    111.3       80.4       38.4 %

GAAP Operating Income

    25.5       15.7       62.2 %

GAAP Operating Margin %

    22.9       19.5          

Adjusted Operating Income*

    33.2       17.9       85.4 %

Adjusted Operating Margin %*

    29.8       22.2          

* Excludes the amortization of acquired backlog, the step-up of inventory to fair value, and acquired intangible assets; Q3 FY24 restated to exclude the amortization of acquired intangible assets

 

Revenue increased approximately $30.9 million or 38.4% year-on-year, reflecting a 48.1% benefit from acquisitions, partially offset by an organic decline of 8.9% and a 0.8% impact from foreign currency. The organic decline was due to continued softness in the automotive end markets in Europe and North America and in general industrial end markets. Adjusted operating income increased approximately $15.3 million or 85.4% year-on-year due to the contribution from the Amran/Narayan Group acquisition, productivity initiatives and product mix, partially offset by lower core volume.

 

The segment had a book-to-bill ratio of approximately 0.98 in the fiscal third quarter, with orders of approximately $109 million. Orders in Electronics core business remained flat sequentially with a continued increase in demand in the electrical grid end market served by Amran/Narayan Group.

 

In fiscal fourth quarter 2025, on a sequential basis, the Company expects slightly higher revenue and similar to slightly higher adjusted operating margin, primarily driven by contributions from the Amran/Narayan Group acquisition, higher sales into fast growth end markets, and price realization, partially offset by higher tariff costs and continued strategic growth investments.

 

2

 

Engraving (14% of sales; 7% of segment adjusted operating income)

 

   

3Q25

   

3Q24

   

% Change

 

Engraving ($M)

                       

Revenue

    30.6       36.3       -15.7 %

GAAP Operating Income

    3.1       6.3       -51.2 %

GAAP Operating Margin %

    10.0       17.2          

Adjusted Operating Income*

    3.4       6.7       -48.8 %

Adjusted Operating Margin %*

    11.2       18.4          

* Excludes the amortization of acquired intangible assets; Q3 FY24 restated to exclude the amortization of acquired intangible assets

 

 

Revenue decreased approximately $5.7 million or 15.7% year-on-year reflecting a 12.6% organic decline, primarily due to continued softness in North America from delays in new platform rollouts, and a foreign currency impact of 3.1%. Adjusted operating income decreased approximately $3.3 million or 48.8% year-on-year due to the lower revenue. Operating deleverage was partially offset by the realization of previously announced productivity initiatives and restructuring actions.

 

In fiscal fourth quarter 2025, on a sequential basis, the Company expects slightly higher revenue and moderately higher adjusted operating margin due to more favorable project timing in Asia, slightly improved demand in North America and Europe, and realization of previously announced restructuring actions.

 

Scientific (9% of sales; 8% of segment adjusted operating income)

 

   

3Q25

   

3Q24

   

% Change

 

Scientific ($M)

                       

Revenue

    18.3       16.9       8.1 %

GAAP Operating Income

    3.9       4.9       -20.4 %

GAAP Operating Margin %

    21.3       28.9          

Adjusted Operating Income*

    4.1       5.1       -19.7 %

Adjusted Operating Margin %*

    22.6       30.4          

* Excludes the amortization of acquired intangible assets; Q3 FY24 restated to exclude the amortization of acquired intangible assets

 

 

Revenue increased approximately $1.4 million or 8.1% year-on-year reflecting a 16.1% benefit from the Custom Biogenic Systems acquisition, partially offset by organic decline of 8.0%, mostly due to lower demand from academic and research institutions that were impacted by NIH funding cuts. Adjusted operating income decreased approximately $1.0 million or 19.7% year-on-year due to organic decline partially offset by contribution from the acquisition.

 

In fiscal fourth quarter 2025, on a sequential basis, the Company expects slightly lower revenue and adjusted operating margin due to soft demand from academic and research institutions affected by NIH funding cuts and higher tariff costs.

 

Engineering Technologies (13% of sales; 10% of segment adjusted operating income)

 

   

3Q25

   

3Q24

   

% Change

 

Engineering Technologies ($M)

                       

Revenue

    27.4       20.1       36.2 %

GAAP Operating Income

    3.4       3.5       -3.0 %

GAAP Operating Margin %

    12.5       17.5          

Adjusted Operating Income*

    5.1       3.5       44.3 %

Adjusted Operating Margin %*

    18.6       17.5          

* Excludes the amortization of acquired backlog, the step-up of inventory to fair value, and acquired intangible assets; Q3 FY24 restated to exclude the amortization of acquired intangible assets

 

3

 

Revenue increased approximately $7.3 million or 36.2% year-on-year reflecting a 26.3% benefit from the recent McStarlite acquisition and organic growth of 9.9%, driven by more favorable project timing in the space end market and growth in sales from new products. Adjusted operating income increased approximately $1.6 million or 44.3% year-on-year reflecting the contribution from the recent acquisition and higher volume.

 

In fiscal fourth quarter 2025, on a sequential basis, the Company expects similar to slightly higher revenue and similar adjusted operating margin.

 

Specialty Solutions (10% of sales; 7% of segment adjusted operating income)

 

   

3Q25

   

3Q24

   

% Change

 

Specialty Solutions ($M)

                       

Revenue

 

20.2

      23.5       -13.9 %

Operating Income

    3.3       4.7       -29.8 %

Operating Margin %

    16.2       19.9          

 

Specialty Solutions revenue decreased approximately $3.3 million or 13.9% year-on-year, reflecting general market softness in the Display Merchandising business and in the Hydraulics business. Operating income decreased approximately $1.4 million or 29.8% year-on-year due to lower volume.

 

In fiscal fourth quarter 2025, on a sequential basis, the Company expects moderately higher revenue and operating margin.

 

Capital Allocation

 

 

Interest: In fiscal fourth quarter 2025, the Company expects interest expense to be approximately $9 million.

 

 

Share Repurchase: During the fiscal third quarter of 2025, the Company didn’t repurchase shares. There was approximately $28 million remaining on the Company’s current share repurchase authorization at the end of the fiscal third quarter 2025.

 

 

Capital Expenditures: In fiscal third quarter 2025, the Company’s capital expenditures were $6.1 million compared to $5.2 million in the fiscal third quarter of 2024. The Company expects fiscal year 2025 capital expenditures between $25 million and $30 million. Capital expenditures were $20.3 million in fiscal 2024.

 

 

Dividend: On April 24, 2025, the Company declared a quarterly cash dividend of $0.32 per share, an approximately 6.7% year-on-year increase. The dividend is payable May 23, 2025, to shareholders of record on May 9, 2025.

 

Balance Sheet and Cash Flow Highlights

 

 

Net Debt: Standex had net (cash) debt of $ 470.4 million on March 31, 2025, compared to $10.0 million at the end of fiscal third quarter 2024. Net (cash) debt for the third quarter of 2025 consisted primarily of long-term debt of $580.2 million and cash and equivalents of $109.8 million.

 

 

Cash Flow: Net cash provided by continuing operating activities for the three months ended March 31, 2025, was $9.6 million compared to $24.4 million in the prior year’s quarter. Free cash flow after capital expenditures was $3.5 million compared to free cash flow after capital expenditures of $19.3 million in the fiscal third quarter of 2024. 

 

Conference Call Details

 

Standex will host a conference call for investors tomorrow, May 2, 2025, at 8:30 a.m. ET. On the call, David Dunbar, President, and CEO, and Ademir Sarcevic, CFO, will review the Company’s financial results and business and operating highlights. Investors interested in listening to the webcast and viewing the slide presentation should log on to the “Investors” section of Standex’s website under the subheading, “Events and Presentations,” located at www.standex.com.

 

4

 

A replay of the webcast will also be available on the Company’s website shortly after the conclusion of the presentation online through May 2, 2026. To listen to the teleconference playback, please dial in the U.S. (888) 660-6345 or (646) 517-4150 internationally; the passcode is 15269#. The audio playback via phone will be available through May 9, 2025. The webcast replay can be accessed in the “Investor Relations” section of the Company’s website, located at www.standex.com.

 

Use of Non-GAAP Financial Measures

 

In addition to the financial measures prepared in accordance with generally accepted accounting principles (“GAAP”), the Company uses certain non-GAAP financial measures, including non-GAAP adjusted income from operations, non-GAAP adjusted net income from continuing operations, free operating cash flow, EBITDA (earnings before interest, taxes, depreciation and amortization) adjusted EBITDA, adjusted EBITDA to net debt, and adjusted earnings per share. The attached financial tables reconcile non-GAAP measures used in this press release to the most directly comparable GAAP measures. The Company believes that the use of non-GAAP measures which exclude the impact of restructuring charges, purchase accounting, amortization from acquired intangible assets, insurance recoveries, discrete tax events, gain or loss on sale of a business unit, acquisition costs, and litigation costs help investors to obtain a better understanding of our operating results and prospects, consistent with how management measures and forecasts the Company's performance, especially when comparing such results to previous periods. An understanding of the impact in a particular quarter of specific restructuring costs, acquisition expenses, or other gains and losses, on net income (absolute as well as on a per-share basis), operating income or EBITDA can give management and investors additional insight into core financial performance, especially when compared to quarters in which such items had a greater or lesser effect, or no effect. Non-GAAP measures should be considered in addition to, and not as a replacement for, the corresponding GAAP measures, and may not be comparable to similarly titled measures reported by other companies.

 

 

About Standex

 

Standex International Corporation is a multi-industry manufacturer in five broad business segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions with operations in the United States, Europe, Canada, Japan, Singapore, Mexico, Turkey, India, and China. For additional information, visit the Company's website at http://standex.com/.

 

5

 

Forward-Looking Statements

 

Statements contained in this Press Release that are not based on historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terminology such as should, could, may, will, expect, believe, estimate, anticipate, intend, continue, or similar terms or variations of those terms or the negative of those terms. There are many factors that affect the Companys business and the results of its operations and that may cause the actual results of operations in future periods to differ materially from those currently expected or anticipated. These factors include, but are not limited to: the impact of pandemics and other global crises or catastrophic events on employees, our supply chain, and the demand for our products and services around the world; materially adverse or unanticipated legal judgments, fines, penalties or settlements; conditions in the financial and banking markets, including fluctuations in exchange rates and the inability to repatriate foreign cash; domestic and international economic conditions, including the impact, length and degree of economic downturns on the customers and markets we serve and more specifically conditions in the electrical grid, automotive, construction, aerospace, defense, transportation, food service equipment, consumer appliance, energy, oil and gas and general industrial markets; lower-cost competition; the relative mix of products which impact margins and operating efficiencies in certain of our businesses; the impact of higher raw material and component costs, particularly steel, certain materials used in electronics parts, petroleum based products, and refrigeration components; the impact of higher transportation and logistics costs, especially with respect to transportation of goods from Asia; the impact of inflation on the costs of providing our products and services; an inability to realize the expected cost savings from restructuring activities including effective completion of plant consolidations, cost reduction efforts including procurement savings and productivity enhancements, capital management improvements, strategic capital expenditures, and the implementation of lean enterprise manufacturing techniques; the potential for losses associated with the exit from or divestiture of businesses that are no longer strategic or no longer meet our growth and return expectations; the inability to achieve the savings expected from global sourcing of raw materials and diversification efforts in emerging markets; the impact on cost structure and on economic conditions as a result of actual and threatened increases in trade tariffs; the inability to attain expected benefits from acquisitions and the inability to effectively consummate and integrate such acquisitions and achieve synergies envisioned by the Company; increased costs from acquisitions to improve and coordinate managerial, operational, financial, and administrative systems, including internal controls over financial reporting and compliance with the Sarbanes-Oxley Act of 2002, and other costs related to such systems in connection with acquired businesses; market acceptance of our products; our ability to design, introduce and sell new products and related product components; the ability to redesign certain of our products to continue meeting evolving regulatory requirements; the impact of delays initiated by our customers; our ability to increase manufacturing production to meet demand including as a result of labor shortages; the impact on our operations of any successful cybersecurity attacks; and potential changes to future pension funding requirements. For a more comprehensive discussion of these and other factors, see the Risk Factors section of the Companys most recent annual report on Form 10-K filed with the SEC and available on the Companys website. In addition, any forward-looking statements represent management's estimates only as of the day made and should not be relied upon as representing management's estimates as of any subsequent date. While the Company may elect to update forward-looking statements at some point in the future, the Company and management specifically disclaim any obligation to do so, even if management's estimates change.

 

 

 

Contact:

Christopher Howe

Director of Investor Relations                           

(773) 754-5394

e-mail: [email protected]

 

6

 

Standex International Corporation

Consolidated Statement of Operations

(unaudited)

 

   

Three Months Ended

   

Nine Months Ended

 
   

March 31,

   

March 31,

 

(In thousands, except per share data)

 

2025

   

2024

   

2025

   

2024

 
                                 

Net sales

  $ 207,780       177,267     $ 568,058     $ 540,441  

Cost of sales

    125,350       108,977       344,108       327,853  

Gross profit

    82,430       68,290       223,950       212,588  
                                 

Selling, general and administrative expenses

    47,564       39,719       130,796       122,466  

(Gain) loss on sale of business

    -       -       -       (274 )

Restructuring costs

    1,976       4,037       3,982       7,303  

Amortization of acquired intangible assets

    4,485       2,045       9,965       6,159  

Acquisition related costs

    2,152       537       20,392       2,233  

Other operating (income) expense, net

    -       110       -       110  
                                 

Income from operations

    26,253       21,842       58,815       74,591  
                                 

Interest expense

    8,363       949       14,915       3,244  

Other non-operating (income) expense, net

    309       627       1,171       1,805  

Total

    8,672       1,576       16,086       5,049  
                                 

Income from continuing operations before income taxes

    17,581       20,266       42,729       69,542  

Provision for income taxes

    (5,197 )     4,327       475       15,639  

Net income from continuing operations

    22,778       15,939       42,254       53,903  
                                 

Income (loss) from discontinued operations, net of tax

    (52 )     (141 )     (56 )     (420 )
                                 

Net income

    22,726       15,798       42,198       53,483  

Less: net income attributable to redeemable noncontrolling interest

    846       -       1,264       -  

Net income attributable to Standex International

  $ 21,880     $ 15,798     $ 40,934     $ 53,483  
                                 

Basic earnings per share:

                               

Income (loss) from discontinued operations

    -       (0.01 )     -       (0.03 )

Total income (loss) attributable to Standex International

  $ 1.83     $ 1.34     $ 3.44     $ 4.55  
                                 

Diluted earnings per share:

                               

Income (loss) from discontinued operations

    -       (0.02 )     -       (0.04 )

Total income (loss) attributable to Standex International

  $ 1.81     $ 1.33     $ 3.41     $ 4.50  
                                 

Average Shares Outstanding

                               

Basic

    11,986       11,772       11,906       11,764  

Diluted

    12,059       11,849       11,997       11,876  

 

7

 

Standex International Corporation

Condensed Consolidated Balance Sheets

(unaudited)

 

   

March 31,

   

June 30,

 

(In thousands)

 

2025

   

2024

 
                 

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 109,810       154,203  

Accounts receivable, net

    169,876       121,365  

Inventories

    119,966       87,106  

Prepaid expenses and other current assets

    87,239       67,421  

Total current assets

    486,891       430,095  
                 

Property, plant, equipment, net

    146,666       134,963  

Intangible assets, net

    226,823       78,673  

Goodwill

    610,740       281,283  

Deferred tax asset

    16,633       17,450  

Operating lease right-of-use asset

    43,314       37,078  

Other non-current assets

    23,489       25,515  

Total non-current assets

    1,067,665       574,962  
                 

Total assets

  $ 1,554,556     $ 1,005,057  
                 

LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND STOCKHOLDERS' EQUITY

         
                 

Current liabilities:

               

Accounts payable

  $ 76,488       63,364  

Accrued liabilities

    59,414       56,698  

Income taxes payable

    7,168       7,503  

Total current liabilities

    143,070       127,565  
                 

Long-term debt

    579,406       148,876  

Operating lease long-term liabilities

    36,611       30,725  

Accrued pension and other non-current liabilities

    80,969       76,388  

Total non-current liabilities

    696,986       255,989  
                 

Redeemable non-controlling interest

    27,573       -  
                 

Stockholders' equity:

               

Common stock

    41,976       41,976  

Additional paid-in capital

    135,241       106,193  

Retained earnings

    1,115,862       1,086,277  

Accumulated other comprehensive loss

    (177,832 )     (182,956 )

Treasury shares

    (428,320 )     (429,987 )

Total stockholders' equity

    686,927       621,503  
                 

Total liabilities, redeemable noncontrolling interest and stockholders' equity

  $ 1,554,556     $ 1,005,057  

 

8

 

Standex International Corporation and Subsidiaries

Statements of Consolidated Cash Flows

(unaudited)

 

   

Nine Months Ended

 
   

March 31,

 

(In thousands)

 

2025

   

2024

 
                 

Cash Flows from Operating Activities

               

Net income

  $ 42,198       53,483  

Income (loss) from discontinued operations

    (56 )     (420 )

Income from continuing operations

    42,254       53,903  
                 

Adjustments to reconcile net income to net cash provided by operating activities:

         

Depreciation and amortization

    25,310       21,146  

Stock-based compensation

    7,878       8,524  

Non-cash portion of restructuring charge

    (401 )     895  

(Gain) loss on sale of business

    -       (274 )

Contributions to defined benefit plans

    (6,153 )     (8,506 )

Net changes in operating assets and liabilities

    (32,675 )     (11,079 )

Net cash provided by operating activities - continuing operations

    36,213       64,609  

Net cash provided by (used in) operating activities - discontinued operations

    (42 )     (497 )

Net cash provided by (used in) operating activities

    36,171       64,112  

Cash Flows from Investing Activities

               

Expenditures for property, plant and equipment

    (19,762 )     (13,765 )

Expenditures for acquisitions, net of cash acquired

    (477,381 )     (47,696 )

Proceeds from the sale of business

    -       7,774  

Other investing activities

    3,800       (270 )

Net cash provided by (used in) investing activities

    (493,343 )     (53,957 )

Cash Flows from Financing Activities

               

Proceeds from borrowings

    792,313       -  

Payments of debt

    (362,109 )     (25,000 )

Activity under share-based payment plans

    2,019       1,325  

Purchase of treasury stock

    (9,582 )     (31,781 )

Cash dividends paid

    (11,197 )     (10,375 )

Net cash provided by (used in) financing activities

    411,443       (65,831 )
                 

Effect of exchange rate changes on cash

    1,336       (1,231 )
                 

Net changes in cash and cash equivalents

    (44,393 )     (56,907 )

Cash and cash equivalents at beginning of year

    154,203       195,706  

Cash and cash equivalents at end of period

  $ 109,810     $ 138,799  

 

9

 

Standex International Corporation

Selected Segment Data

(unaudited)

 

   

Three Months Ended

   

Nine Months Ended

 
   

March 31,

   

March 31,

 

(In thousands)

 

2025

   

2024

   

2025

   

2024

 

Net Sales

                               

Electronics

  $ 111,283     $ 80,431     $ 284,939     $ 241,538  

Engraving

    30,585       36,297       95,402       117,936  

Scientific

    18,292       16,925       54,462       51,410  

Engineering Technologies

    27,375       20,098       70,555       58,205  

Specialty Solutions

    20,245       23,516       62,700       71,352  

Total

  $ 207,780     $ 177,267     $ 568,058     $ 540,441  
                                 

Income from operations

                               

Electronics

  $ 25,471     $ 15,700     $ 59,918     $ 47,884  

Engraving

    3,058       6,260       13,004       22,765  

Scientific

    3,895       4,896       13,362       14,074  

Engineering Technologies

    3,417       3,524       11,120       9,946  

Specialty Solutions

    3,278       4,668       10,388       14,250  

Restructuring

    (1,976 )     (4,037 )     (3,982 )     (7,303 )

Gain (loss) on sale of business

    -       -       -       274  

Acquisition related costs

    (2,152 )     (537 )     (20,392 )     (2,233 )

Corporate

    (8,738 )     (8,522 )     (24,603 )     (24,956 )

Other operating income (expense), net

    -       (110 )     -       (110 )

Total

  $ 26,253     $ 21,842     $ 58,815     $ 74,591  

 

10

 

Standex International Corporation

Reconciliation of GAAP to Non-GAAP Financial Measures

(unaudited)

 

   

Three Months Ended

           

Nine Months Ended

         
   

March 31,

           

March 31,

         

(In thousands, except percentages)

 

2025

   

2024

   

% Change

   

2025

   

2024

   

% Change

 

Adjusted income from operations and adjusted net income from continuing operations:

                                               

Net Sales

  $ 207,780     $ 177,267       17.2 %   $ 568,058     $ 540,441       5.1 %

Income from operations, as reported

  $ 26,253     $ 21,842       20.2 %   $ 58,815     $ 74,591       -21.2 %

Income from operations margin

    12.6 %     12.3 %             10.4 %     13.8 %        

Adjustments:

                                               

Restructuring charges

    1,976       4,037               3,982       7,303          

Acquisition-related costs

    2,152       537               20,392       2,233          

Amortization of acquired intangible assets

    4,485       2,045               9,965       6,159          

(Gain) loss on sale of business

    -       -               -       (274 )        

Environmental remediation

    -       110               -       110          

Purchase accounting expenses

    5,479       818               11,676       1,463          

Adjusted income from operations

  $ 40,345     $ 29,389       37.3 %   $ 104,830     $ 91,585       14.5 %

Adjusted income from operations margin

    19.4 %     16.6 %             18.5 %     16.9 %        

Interest and other income (expense), net

    (8,672 )     (1,576 )             (16,086 )     (5,049 )        

Foreign currency related (gain) loss on acquisition and divestiture activities

    -       591               554       309          

Provision for income taxes

    5,197       (4,327 )             (475 )     (15,639 )        

Discrete and other tax items

    (9,321 )     -               (8,946 )     100          

Tax impact of above adjustments

    (3,173 )     (1,794 )             (10,314 )     (3,953 )        

Net income from continuing operations, as adjusted

    24,375       22,283       9.4 %     69,563       67,353       3.3 %

Less: net income attributable to redeemable noncontrolling interest

    846       -               1,264       -          

Net income attributable to Standex International, as adjusted

  $ 23,530     $ 22,283       5.6 %   $ 68,299     $ 67,353       1.4 %
                                                 

EBITDA and Adjusted EBITDA:

                                               

Net income (loss) from continuing operations, as reported

  $ 22,778     $ 15,939       42.9 %   $ 42,254     $ 53,903          

Net income from continuing operations margin

    11.0 %     9.0 %             7.4 %     10.0 %        

Add back:

                                               

Provision for income taxes

    (5,197 )     4,327               475       15,639          

Interest expense

    8,363       949               14,915       3,244          

Depreciation and amortization

    9,744       7,177               25,310       21,146          

EBITDA

  $ 35,688     $ 28,392       25.7 %   $ 82,954     $ 93,932       -11.7 %

EBITDA Margin

    17.2 %     16.0 %             14.6 %     17.4 %        

Adjustments:

                                               

Restructuring charges

    1,976       4,037               3,982       7,303          

Acquisition-related costs

    2,152       537               20,392       2,233          

(Gain) loss on sale of business

    -       -               -       (274 )        

Foreign currency related (gain) loss on acquisition and divestiture activities

    -       591               -       309          

Environmental remediation

    -       110               -       110          

Purchase accounting expenses

    5,479       818               11,676       1,463          

Adjusted EBITDA

  $ 45,295     $ 34,485       31.3 %   $ 119,004     $ 105,076       13.3 %
      21.8 %     19.5 %             20.9 %     19.4 %        

Free operating cash flow:

                                               

Net cash provided by operating activities - continuing operations, as reported

  $ 9,551     $ 24,442             $ 36,213     $ 64,609          

Less: Capital expenditures

    (6,072 )     (5,178 )             (19,762 )     (13,765 )        

Free cash flow from continuing operations

  $ 3,479     $ 19,264             $ 16,451     $ 50,844          

 

11

 

Standex International Corporation

Reconciliation of GAAP to Non-GAAP Financial Measures

(unaudited)

 

   

Three Months Ended

           

Nine Months Ended

         

 

 

March 31,

           

March 31,

         
Adjusted earnings per share from continuing operations  

2025

   

2024

   

%
Change

   

2025

   

2024

   

% Change

 
                                                 

Diluted earnings per share from net income attributable to Standex, as reported

  $ 1.81     $ 1.35       34.4 %   $ 3.41     $ 4.54       -24.8 %
                                                 

Adjustments:

                                               

Restructuring charges

    0.13       0.26               0.25       0.48          

Acquisition-related costs

    0.14       0.04               1.36       0.14          

Amortization of acquired intangible assets

    0.29       0.13               0.63       0.40          

Gain on bargain purchase

    -       -               -       -          

Litigation (settlement refund) charge

    -       -               -       -          

(Gain) loss on sale of business

    -       -               -       (0.02 )        

Foreign currency related (gain) loss on acquisition and divestiture activities

    -       0.04               0.04       0.02          

Environmental remediation

    -       0.01               -       0.01          

Discrete tax items

    (0.77 )     -               (0.74 )     0.01          

Purchase accounting expenses

    0.35       0.05               0.74       0.09          

Diluted earnings per share from net income attributeable to Standex, as adjusted

  $ 1.95     $ 1.88       3.6 %   $ 5.69     $ 5.67       0.3 %

 

12